Back to today’s briefing

Story perspectives

States Push for Prescription Drug Price Reforms Amid Federal Inaction

6/12/2025

29 4

Summary

Story summary

Across the U.S., states like Michigan, Arkansas, California, Illinois, Alabama, and New Jersey are stepping up to tackle prescription drug prices. New bills aim to boost transparency and safeguard pharmacies, with advocates urging that savings must benefit patients directly. However, critics caution about the potential strain on employers. This movement reflects a rising tide of state-led reforms in the face of federal inaction.

History

Historical Context

The Medicare Prescription Drug, Improvement, and Modernization Act, enacted in 2003, established Medicare Part D, allowing seniors access to prescription drugs but prohibiting Medicare from negotiating prices. This led to a 10% rise in drug spending. In response to ongoing affordability issues, states like Michigan and California are now pursuing legislation aimed at enhancing transparency and reducing costs for patients.

1 of 2

Story summary

Across the U.S., states like Michigan, Arkansas, California, Illinois, Alabama, and New Jersey are stepping up to tackle prescription drug prices. New bills aim to boost transparency and safeguard pharmacies, with advocates urging that savings must benefit patients directly. However, critics caution about the potential strain on employers. This movement reflects a rising tide of state-led reforms in the face of federal inaction.

1 / 2